Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04696653 · ClinicalTrials.gov registry record · NA

A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations

A NA study of Hypertension and Diabetes Mellitus, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT04696653: Completed NA study of Hypertension and Diabetes Mellitus, sponsored by Johns Hopkins University.

NCT04696653 is a NA study of Hypertension and Diabetes Mellitus that has completed, run by Johns Hopkins University. The registered enrollment target is 85 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04696653, a NA study of Hypertension and Diabetes Mellitus, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

This pilot study will examine whether an implementation strategy will improve delivery of evidence-based care for cardiovascular risk factors for people with serious mental illness.

Primary Outcome

Each of the items in the modified survey is scored individually on 1-5 Likert scales. An average score is calculated by summing responses across all items and dividing by the total number of items. The average score ranges from 1-5. A higher average score signifies an organizational culture that is more supportive of quality improvement.

Interventions

  • OTHER Comprehensive Unit Based Safety Program (CUSP)

Study Locations (1)

Maryland

  • Johns Hopkins Adult Psychiatric Rehabilitation Program - Baltimore

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2021-02-24
Est. Completion 2023-04-05
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT04696653 record still lists

NCT04696653 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Unit Based Safety Program (CUSP) is the first listed.

NCT04696653 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04696653 about?

NCT04696653 is a clinical study titled "A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations". This pilot study will examine whether an implementation strategy will improve delivery of evidence-based care for cardiovascular risk factors for people with serious mental illness.

What is the current status of trial NCT04696653?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2021-02-24. Estimated completion is 2023-04-05.

What conditions does trial NCT04696653 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Dyslipidemias.

What interventions are being tested in trial NCT04696653?

The interventions under investigation include: Comprehensive Unit Based Safety Program (CUSP) (OTHER).

Who is sponsoring clinical trial NCT04696653?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04696653 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04696653's enrollment target sits among peer trials

85 313th of 470 higher than 156 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04696653, the US trial registry maintained by the National Library of Medicine. NCT04696653 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.